WYC-210 |
Catalog No.GC60386 |
타자로텐 유도체인 WYC-210은 레티노이드계 화합물로 항암 활성이 낮습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2131803-93-3
Sample solution is provided at 25 µL, 10mM.
WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1].
WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1].
[1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
Review for WYC-210
Average Rating: 5
(Based on Reviews and 33 reference(s) in Google Scholar.)Review for WYC-210
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *